MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/14/2026, 08:32 AM (Berlin time), refresh in progress.

Apotex Health Stock

Apotex Health Corp.

APTX.TOTSXMarkt
CA$31.74
+1.4% today

Company data

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Canada
CEO
Jeff Watson
Employees
6,000
Market cap
$7.3 B
IPO
11/06/2026

Apotex Health Corp. is a healthcare company headquartered in Toronto, Canada. Founded in 1974, the company operates as a subsidiary of SK Artemis Holdings, II, LLC. The firm develops, manufactures, and distributes an extensive portfolio consisting of prescription and generic pharmaceuticals, oncology biosimilar…

Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.

Apotex Health stock: price history

10/06/26+17.6 %16/10/26

1D

+1.4%

1W

+3.1%

1M

-3.5%

6M

–

YTD

–

1Y

–

2Y

–

5Y

–

10Y

–

Ask the agents about Apotex Health

Free float & liquidity

FREE FLOAT

–

FLOAT SHARES

69,824,731

AVG. DAILY VOLUME (30D)

604,557

Dividends

EX-DATEPAY DATEAMOUNTYIELD
15/09/202630/09/2026CA$0.060.2 %

Comparable stocks

Frequently asked questions about Apotex Health stock

What does Apotex Health do?

Apotex Health Corp. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.

The CEO is Jeff Watson, the company employs around 6,000 people.

The IPO was on 11/06/2026; the stock trades on TSX under the ticker APTX.TO.

Does Apotex Health pay a dividend?

Yes. The last dividend was CA$0.06 per share, ex-date 15/09/2026, paid on 30/09/2026.

Which stocks are comparable to Apotex Health?

Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.

How can I get Apotex Health stock analyzed?

Clicking "Analyze stock" lets five strategies assess Apotex Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.